0000899243-17-018635.txt : 20170720 0000899243-17-018635.hdr.sgml : 20170720 20170720163612 ACCESSION NUMBER: 0000899243-17-018635 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170718 FILED AS OF DATE: 20170720 DATE AS OF CHANGE: 20170720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pomerantz Roger CENTRAL INDEX KEY: 0001614936 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37465 FILM NUMBER: 17974659 MAIL ADDRESS: STREET 1: 711 HARVEST HILL ROAD CITY: CHALFONT STATE: PA ZIP: 18914 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seres Therapeutics, Inc. CENTRAL INDEX KEY: 0001609809 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274326290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617 945 9626 MAIL ADDRESS: STREET 1: 200 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Seres Health, Inc. DATE OF NAME CHANGE: 20140603 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-18 0 0001609809 Seres Therapeutics, Inc. MCRB 0001614936 Pomerantz Roger C/O SERES THERAPEUTICS, INC. 200 SIDNEY STREET CAMBRIDGE MA 02139 1 1 0 0 President and CEO Common Stock 2017-07-18 4 M 0 100604 0.71 A 284296 D Stock Option (right to buy) 0.71 2017-07-18 4 M 0 100604 0.00 D 2024-08-07 Common Stock 100604 951682 D The option vested as to 25% of the shares on June 1, 2015. The remainder of the shares have vested or will vest in 12 equal quarterly installments thereafter. /s/ Thomas J. DesRosier, Attorney-in-Fact 2017-07-20